X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

VIRCHOWS ARCHIV

期刊標題檢索 VIRCHOWS ARCH 最新評論: Prompt manuscript processing, meticulous reviewers, and fair feedback!... (2024-01-28)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[VIRCHOWS ARCHIV]您好,您是該頁面的第 20030 位訪客。

期刊簡介
期刊名稱VIRCHOWS ARCHIV VIRCHOWS ARCHIV
LetPub Score
6.4
50 ratings
Rate

Reputation
7.6

Influence
5.2

Speed
7.1

期刊簡稱VIRCHOWS ARCH
ISSN0945-6317
E-ISSN1432-2307
h-index90
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.401.0921.279
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pathology and Forensic Medicine
Q130 / 208
Category: Medicine
Subcategory: Molecular Biology
Q2149 / 410
Category: Medicine
Subcategory: Cell Biology
Q2117 / 285

自引率 (2023-2024)2.90%自引率趨勢
掲載範囲
Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.
官方網站https://www.springer.com/428
在線稿件提交https://www.editorialmanager.com/viar
開放訪問No
出版商Springer Berlin Heidelberg
主題領域医学
出版國/地區GERMANY
發行頻率月刊
創刊年1847
每年文章數196每年文章數趨勢
黃金OA百分比37.72%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PATHOLOGYSCIEQ122/88
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0945-6317%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【VIRCHOWS ARCHIV】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Annual Review of Pathology-Mechanisms of DiseaseH-index: 105

    CiteScore: 62.60
    ENDOCRINE PATHOLOGYH-index: 42

    CiteScore: 12.30
    ACTA NEUROPATHOLOGICAH-index: 146

    CiteScore: 23.70
    Seminars in ImmunopathologyH-index: 85

    CiteScore: 19.80
    MODERN PATHOLOGYH-index: 139

    CiteScore: 14.30
    BRAIN PATHOLOGYH-index: 124

    CiteScore: 13.20
    JOURNAL OF PATHOLOGYH-index: 168

    CiteScore: 14.10
    ADVANCES IN ANATOMIC PATHOLOGYH-index: 69

    CiteScore: 10.30
    LABORATORY INVESTIGATIONH-index: 140

    CiteScore: 8.30
    AMERICAN JOURNAL OF PATHOLOGYH-index: 258

    CiteScore: 11.40
    學科內最受檢索的期刊 頁面查看次數
    Molecular Medicine Reports314297
    DISEASE MARKERS92609
    PATHOLOGY RESEARCH AND PRACTICE68295
    LABORATORY INVESTIGATION67483
    JOURNAL OF PATHOLOGY65723
    AMERICAN JOURNAL OF PATHOLOGY61174
    ACTA NEUROPATHOLOGICA44157
    Diagnostic Pathology43859
    PATHOLOGY & ONCOLOGY RESEARCH43747
    MODERN PATHOLOGY41698
  •  

    VIRCHOWS ARCHIV VIRCHOWS ARCHIV
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [VIRCHOWS ARCHIV] 的評論撰寫評論
作者: chengchenga


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2024-01-28 10:05:46 評論於
Prompt manuscript processing, meticulous reviewers, and fair feedback!
10.31 Submitted to the journal
11.1 With editor
11.7 Under Review
11.22 Required Reviews Completed
11.23 Decision in process
11.24 Major revision
12.8 Revision submitted to the journal
12.12 With editor
12.16 Under Review
12.27 Required Reviews Completed
1.4 Minor revision
1.14 Revision Submitted to Journal
1.16 With editor
1.24 Decision in process
1.27 Accept
(0) 讚! | chengchenga

作者: Norma Wilmott


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-27 18:37:49 評論於
The manuscript was handled very quickly, the reviewers were very careful, and the suggestions were very constructive!
10.31  Submitted to the journal
11.1   With editor
11.7   Under Review
11.22  Required Reviews Completed
11.23  Decision in process
11.24  Major revision
12.8   Revision submitted to the journal
12.12  With editor
12.16  Under Review
12.27  Required Reviews Completed
1.4    Minor revision
1.14   Revision Submitted to Journal
1.16   With editor
1.24   Decision in process
1.27   Accept
(0) 讚! | Norma Wilmott

作者: Norma Wilmott


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-27 14:52:09 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Emphasized research direction: Pathological morphology
Experience sharing: The manuscript processing is very fast, the reviewers are very serious, and the suggestions are very pertinent
10.31 Submitted to the journal
11.1 With editor
11.7 Under Review
11.22 Required Reviews Completed
11.23 Decision in process
11.24 Major revision
12.8 Revision submitted to the journal
12.12 With editor
12.16 Under Review
12.27 Required Reviews Completed
1.4 Minor revision
1.14 Revision Submitted to Journal
1.16 With editor
1.24 Decision in process
1.27 Accept
(0) 讚! | Norma Wilmott

作者: Norma Wilmott


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-27 12:31:19 評論於
10.31 Submitted to the journal
11.1 With editor
11.7 Under Review
11.22 Required Reviews Completed
11.23 Decision in process
11.24 Major revision
12.8 Revision submitted to the journal
12.12 With editor
12.16 Under Review
12.27 Required Reviews Completed
1.4 Minor revision
1.14 Revision submitted to Journal
1.16 With editor
1.24 Decision in process
1.27 Accept
(0) 讚! | Norma Wilmott

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:35:35 評論於
The introduction should outline the challenges you want to address and the questions you want to answer, summarizing existing research and gaps in knowledge
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:27:54 評論於
Introduction writing focuses on proposing the unresolved problems and the innovative or valuable aspects of one's research. 
Discussion section requires in-depth comparison and analysis of one's research results with previous findings. The emphasis is different between the two
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 17:01:02 評論於
Introduction and discussion are different in how they are written
(0) 讚! | 陶宜三岁啦

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 17:08:35 評論於
How to write an introduction? Different from discussion?
(0) 讚! | 魂魄彦露

作者: 谷蓝大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-09-23 18:57:53 評論於
In classic pathology journals, there are few articles written by Chinese authors. Not good
(0) 讚! | 谷蓝大叔

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [VIRCHOWS ARCHIV] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*